Histamine glutarimide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameHistamine glutarimide
Drug Alias NameXC-8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor modulators
TargetsHistamine receptor
Therapy Area/IndicationsPulmonary EosinophiliaAsthmaInfluenza, Human +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationAustriaGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEurrus Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesEurrus Biotech GmbhChemlmmune Therapeutics LLCValenta Pharm Jsc
Inactive CompaniesPharmenterprises Llc
Active IndicationsPulmonary EosinophiliaAsthmaInfluenza, Human +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A